This transcript has been edited for clarity.
There is wonderful news in the field of hybrid closed-loop pump technology because the Medtronic 780G system was just approved. I can't tell you how happy this makes me because we've all been waiting for this seemingly forever and ever. This isn't just a small upgrade from the 770G. It's a quantum leap from the 770G to the 780G. The 780G has newer algorithms, a new sensor, and a longer-lasting infusion set.
It's been used since 2020 in Europe, so we have good data on how well it works. Frankly, I think it works really well. We've seen nice improvements in A1c, time in range, other glycemic metrics, and patient satisfaction in studies done in Europe.
Now, I've never had the system to use in one of my patients. I always say I never know a system until I see it in use in my own patients but let me tell you what I've read.
First, it has something called meal-detection technology with autocorrection boluses every 5 minutes. If this works, it can be a huge win for our patients because the problem my patients have is with mealtime dosing. They often dose late, or they may not dose enough insulin for the carbohydrates. That's where the issues are.
All these hybrid closed-loop systems, this one included, show that the best improvements in glycemia are overnight. I'm hoping that this one shows some nice improvements in daytime glycemia as well. Stay tuned and I'll let you know once I've been using it.
Next, it has adjustable targets down to 100. This is the lowest target for any hybrid closed-loop system. It has an extended-wear infusion set that lasts for 7 days. This infusion set is already available but works with this new system.
Finally, it has a new sensor. It looks like the old sensors, but it's the Guardian 4, which requires much fewer finger sticks. Now, I'm not entirely sure about how often one has to do a finger stick. I know one has to do with finger sticking to initiate auto mode, or what they call SmartGuard, but I don't know whether you ever have to do it again. I know for sure that you have to do it again if you fall out of the automated mode into manual mode. Once you're in SmartGuard, I believe there are no further finger-stick calibrations required.
If people are already on the 770G system, this is just a software update that is presumably easy to upgrade to the 780G. Now, the physical pieces… If someone doesn't already have the Guardian 4 sensor or the extended-wear infusion set, they'll have to get those. The software update to make the 770G increase to the 780G should just come through the cloud. I don't know when that's going to happen.
I do know that preorders for this system, if you want to buy the new physical system, start on May 15. The shipping of the new 780G system, should occur in the United States toward the end of this summer.
I'm so excited. I think this is really going to benefit my patients. I can't wait to start using it and letting patients see how these algorithms work and how they really help patients improve their glucose control.
Anne L. Peters, MD, is a professor of medicine at the University of Southern California (USC) Keck School of Medicine and director of the USC clinical diabetes programs. She has published more than 200 articles, reviews, and abstracts, and three books, on diabetes, and has been an investigator for more than 40 research studies. She has spoken internationally at over 400 programs and serves on many committees of several professional organizations.
For more diabetes and endocrinology news, follow us on Twitter and Facebook
Follow Medscape on Facebook, Twitter, Instagram, and YouTube
Medscape Diabetes © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Why the Approval of MiniMed 780G Is a 'Quantum Leap' Forward - Medscape - Apr 26, 2023.
Comments